2015 Executive Compensation Schedule for NewLink Genetics Corporation

Summary

This document outlines the 2015 compensation details for four executives at NewLink Genetics Corporation. It specifies each executive's base salary, target bonus as a percentage of salary, and the number of stock options and restricted stock units awarded. The agreement sets out the compensation structure for the Chairman/CEO, President/CMO, Clinical and Regulatory Affairs Officer, and VP of Business Development for the year 2015.

EX-10.2 3 nlnk-20150106x8kxex102.htm EXHIBIT - 2015 NLNK-20150106-8K-EX10.2
Exhibit 10.2


2015 Salaries, Bonus Targets and Equity Awards
Name and Title
2015 Salary
Bonus Target*
Stock Options
Restricted Stock Unit Awards
Charles J. Link, Jr., M.D.
$640,700
60
%
143,000

45,000

Chairman of the Board and Chief
Executive and Scientific Officer
Nicholas N. Vahanian, M.D.
$531,800
50
%
81,000

25,000

President and Chief Medical Officer
W. Jay Ramsey, M.D., Ph.D.
$345,800
35
%
24,800

7,800

Clinical and Regulatory Affairs Officer
Brian Wiley
$319,600
30
%
23,400

7,400

Vice President of Business Development
 
 
 
 
 
* Bonus Targets listed as percentage of 2015 Base Salary